Researchers Develop Vaccine Candidates to Prevent Epstein-Barr Virus
An NIH research team has determined how several antibodies induced by Epstein-Barr virus (EBV) block infection of cells grown in the laboratory.
Sanofi Receives Narrow FDA Approval for Dengue Vaccine
FDA has given Sanofi SA’s dengue vaccine Dengvaxia a narrow approval since the vaccine can cause severe infections in some people.
Campaign Launched to Remind Families Teens Need Second Meningitis Booster Shot
The National Meningitis Association has launched a campaign to encourage more teens to get the meningitis booster.
FDA Approves Expanded Use of Doptelet to Treat Thrombocytopenia
FDA has approved an expanded indication for Dova Pharmaceuticals’ Doptelet (avatrombopag) to treat adults with chronic immune thrombocytopenia.
Connecting with People Who Have Suffered from Diseases Can Change Attitudes Toward Vaccines
A BYU study found introducing vaccine-hesitant people to people affected by vaccine-preventable diseases can decrease vaccine hesitancy.
Genetics Linked to Immunity to Childhood Vaccines
Researchers at the University of Oxford in the United Kingdom have linked several genetic variations with the level of protective antibodies generated following routine childhood immunizations.
2018-19 Flu Season Separated by Two Waves Was Longest in Decade
The 2018-19 influenza (flu) season was both the longest in a decade and marked by two separate waves of influenza A, CDC says.
FDA Approves Pediatric Hexavalent Combination Vaccine
Sanofi and Merck’s Vaxelis has been approved by the U.S. Food and Drug Administration.
Researchers Discover New, Rare Autoimmune Disease
A previously unknown autoimmune muscle disease involving sudden onset of debilitating muscle pain and weakness has been identified by researchers at Washington University School of Medicine in St. Louis, Mo.
Flu Pamphlet Impacts Parents’ Decision to Vaccinate Kids
A new study by researchers at Columbia University has found handing a pamphlet about influenza (flu) to parents in pediatricians’ waiting rooms can have a significant impact on increasing the uptake of the flu vaccine.